Dual biologic therapy in a patient with severe psoriasis and psoriatic arthritis, using guselkumab and bimekizumab: A case report and review of the literature. [PDF]
Muylaert Barrett B, Music M, Yadav G.
europepmc +1 more source
Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis. [PDF]
Marzo-Ortega H +8 more
europepmc +1 more source
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. [PDF]
Alexis A +16 more
europepmc +1 more source
Comparison of the Effects and Safety of Planned Limited-Time Withdrawal Versus Continuous Maintenance of Interleukin Inhibitors in Patients with Psoriasis: A Systematic Review and Network Meta-Analysis. [PDF]
de Sena RR +5 more
europepmc +1 more source
Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review. [PDF]
Deng S +6 more
europepmc +1 more source
Early and Mid-Term Ultrasound Response to Guselkumab in Psoriatic Arthritis: A Real-World Cohort from a Single Tertiary Rheumatology Center. [PDF]
Messina F +5 more
europepmc +1 more source
Real-World Comparison of On-Label Treatment Persistence Through 24 Months Between Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Interleukin-17A Inhibitors. [PDF]
Mease PJ +13 more
europepmc +1 more source
Navigating the Misdiagnosis of Pityriasis Rubra Pilaris and Successful Treatment With Guselkumab: A Case Report of Dual Biologic Therapy. [PDF]
Bongfeldt D, Martinez-Cabriales S.
europepmc +1 more source
Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators. [PDF]
Schmidt M +3 more
europepmc +1 more source
Case Report: Successful management of refractory SAPHO syndrome with guselkumab-upadacitinib combination. [PDF]
Jin D +5 more
europepmc +1 more source

